PriceTargets.com logo

Moelis & Company - MC Stock Price Target and Predictions

  • Consensus Rating: Sell
  • Consensus Price Target: $38.86
  • Forecasted Upside: 2.93%
  • Number of Analysts: 7
  • Breakdown:
  • 5 Sell Ratings
  • 2 Hold Ratings
  • 0 Buy Ratings
  • 0 Strong Buy Ratings
$37.75 As of 03/24/2023 01:00 AM ET
▼ -0.83 (-2.15%)

This chart shows the closing price for MC by one month, three months, or twelve months.

Skip Closing Price Chart
1 month | 3 months | 12 months
Get New Moelis & Company Analyst Ratings Delivered To Your Inbox
Sign-up to receive the latest news and ratings for MC and its competitors with Analyst Ratings Network’s free daily newsletter.

Analyst Price Target for MC

Analyst Price Target is $38.86
▲ +2.93% Upside Potential
This price target is based on 7 analysts offering 12 month price targets for Moelis & Company in the last 3 months. The average price target is $38.86, with a high forecast of $45.00 and a low forecast of $30.00. The average price target represents a 2.93% upside from the last price of $37.75.

This chart shows the closing price for MC for the last year in relation to the current analyst high, average, and low pricetarget.

Read Analyst Price Chart DescriptionSkip Analyst Price Chart

Current Consensus is Sell

The current consensus among 7 contributing investment analysts is to sell stock in Moelis & Company. This Sell consensus rating has held steady for over two years.

Past Monthly Recommendations

Move your mouse over past months for details

Read Past Recommendations DescriptionSkip Past Price Target Consensus Chart
  • 0 strong buy ratings
  • 0 buy ratings
  • 3 hold ratings
  • 4 sell ratings
Ratings as of
10/2/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 4 sell ratings
Ratings as of
12/31/2021
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
Ratings as of
3/31/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 4 sell ratings
Ratings as of
6/29/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 1 hold ratings
  • 5 sell ratings
Ratings as of
9/27/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
Ratings as of
12/26/2022
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
Ratings as of
2/24/2023
  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings
Ratings as of
3/26/2023

Latest Recommendations

  • 0 strong buy ratings
  • 0 buy ratings
  • 2 hold ratings
  • 5 sell ratings

Display Ratings By
DateBrokerageActionRatingPrice TargetImpact on Share PriceDetails
2/9/2023The Goldman Sachs GroupBoost TargetSell$38.00 ➝ $42.00Low
1/11/2023The Goldman Sachs GroupDowngradeNeutral ➝ Sell$40.00 ➝ $37.00Low
1/9/2023UBS GroupLower TargetSell$32.00 ➝ $30.00Low
11/3/2022JPMorgan Chase & Co.Lower TargetNeutral$42.00 ➝ $40.00Low
11/3/2022Keefe, Bruyette & WoodsDowngradeMarket Perform ➝ Underperform$40.00 ➝ $37.00Low
10/7/2022The Goldman Sachs GroupLower TargetNeutral$43.00 ➝ $38.00Low
9/23/2022UBS GroupDowngradeNeutral ➝ Sell$43.00 ➝ $35.00Low
7/28/2022UBS GroupBoost TargetNeutral$40.00 ➝ $43.00Low
7/18/2022Morgan StanleyDowngradeEqual Weight ➝ Underweight$53.00 ➝ $36.00Low
7/11/2022Wolfe ResearchDowngradePeer Perform ➝ Underperform$42.00N/A
7/8/2022Piper SandlerLower TargetNeutral$50.00 ➝ $45.00N/A
7/6/2022UBS GroupDowngradeBuy ➝ Neutral$54.00 ➝ $40.00N/A
4/28/2022Piper SandlerDowngradeOverweight ➝ Neutral$52.00 ➝ $50.00High
4/12/2022The Goldman Sachs GroupLower TargetNeutral$50.00 ➝ $45.00Medium
4/7/2022Piper SandlerLower TargetOverweight$61.00 ➝ $52.00High
4/6/2022Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$57.00High
3/9/2022Piper SandlerLower TargetOverweight ➝ Overweight$70.00 ➝ $61.00High
3/8/2022Morgan StanleyLower TargetEqual Weight$65.00 ➝ $53.00Low
2/11/2022Piper SandlerUpgradeNeutral ➝ Overweight$78.00 ➝ $70.00High
2/10/2022Morgan StanleyLower TargetEqual Weight$68.00 ➝ $65.00High
1/6/2022The Goldman Sachs GroupUpgradeSell ➝ Neutral$68.00 ➝ $65.00High
1/4/2022UBS GroupLower TargetBuy$85.00 ➝ $73.00Medium
12/17/2021Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$77.00High
12/8/2021Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$75.00 ➝ $68.00High
10/11/2021Morgan StanleyBoost TargetEqual Weight$63.00 ➝ $68.00Low
7/22/2021Morgan StanleyBoost TargetEqual Weight$60.00 ➝ $63.00High
6/17/2021Wolfe ResearchUpgradeUnderperform ➝ Peer Perform$63.00High
4/15/2021JMP SecuritiesReiterated RatingMarket Outperform ➝ Market PerformHigh
4/9/2021JMP SecuritiesDowngradeOutperform ➝ Market PerformMedium
4/7/2021Morgan StanleyBoost TargetEqual Weight$57.00 ➝ $60.00Low
3/16/2021Piper SandlerBoost Target$58.00 ➝ $68.00Low
2/11/2021Morgan StanleyBoost TargetEqual Weight$55.00 ➝ $57.00Low
1/11/2021Morgan StanleyBoost TargetEqual Weight$52.00 ➝ $55.00Medium
1/7/2021JPMorgan Chase & Co.UpgradeUnderweight ➝ Neutral$34.00 ➝ $50.00N/A
1/5/2021UBS GroupUpgradeNeutral ➝ Buy$40.00 ➝ $56.00N/A
12/14/2020Morgan StanleyBoost TargetEqual Weight$41.00 ➝ $52.00Medium
10/27/2020Piper SandlerBoost TargetNeutral$37.00 ➝ $41.00Medium
10/12/2020Morgan StanleyBoost TargetEqual Weight$29.00 ➝ $41.00Low
10/9/2020JMP SecuritiesBoost TargetMarket Outperform$37.00 ➝ $42.00Low
10/9/2020Keefe, Bruyette & WoodsDowngradeOutperform ➝ Market Perform$40.00Medium
10/2/2020UBS GroupUpgradeSell ➝ Neutral$38.00High
8/5/2020The Goldman Sachs GroupDowngradeNeutral ➝ Sell$27.00 ➝ $24.00Medium
7/30/2020Piper SandlerLower TargetNeutral$32.00 ➝ $31.00Medium
7/30/2020Morgan StanleyLower TargetEqual Weight$31.00 ➝ $29.00High
7/22/2020Wolfe ResearchInitiated CoverageUnderperform$19.00High
7/13/2020The Goldman Sachs GroupDowngradeBuy ➝ Neutral$34.00 ➝ $27.00High
7/10/2020Piper SandlerDowngradeOverweight ➝ Neutral$40.00 ➝ $32.00High
7/7/2020JPMorgan Chase & Co.DowngradeNeutral ➝ Underweight$20.00 ➝ $26.00High
4/14/2020UBS GroupDowngradeNeutral ➝ Sell$22.00Low
4/9/2020JMP SecuritiesLower TargetMarket Outperform$45.00 ➝ $39.00Low
4/9/2020Morgan StanleyLower TargetEqual Weight$37.00 ➝ $31.00Medium
3/25/2020UBS GroupLower TargetNeutral$33.00 ➝ $28.00Low
3/23/2020JPMorgan Chase & Co.DowngradeOverweight ➝ Neutral$20.00Medium
2/6/2020JPMorgan Chase & Co.Boost TargetOverweight$44.00 ➝ $49.00High
2/6/2020Buckingham ResearchBoost TargetBuy$39.00 ➝ $41.00High
1/26/2020Keefe, Bruyette & WoodsUpgradeMarket Perform ➝ Outperform$34.00 ➝ $39.00Low
12/11/2019Morgan StanleyLower TargetEqual Weight$37.00 ➝ $35.00Medium
10/9/2019Buckingham ResearchLower TargetBuy$44.00 ➝ $39.00Low
10/8/2019Morgan StanleyLower TargetEqual Weight$41.00 ➝ $39.00Medium
7/31/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Market Perform$42.00 ➝ $39.00Low
7/11/2019Buckingham ResearchLower TargetBuy$53.00 ➝ $44.00Medium
7/8/2019Morgan StanleyLower TargetEqual Weight$45.00 ➝ $41.00Low
4/11/2019Bank of AmericaDowngradeBuy ➝ UnderperformMedium
4/8/2019JMP SecuritiesLower TargetMarket Outperform ➝ Market Outperform$56.00 ➝ $50.00Low
1/8/2019Morgan StanleyLower TargetEqual Weight ➝ Equal Weight$59.00 ➝ $46.00Low
1/4/2019Keefe, Bruyette & WoodsReiterated RatingOutperform ➝ Outperform$43.00Medium
12/7/2018Sandler O'NeillUpgradeHold ➝ Buy$45.00Medium
11/6/2018The Goldman Sachs GroupInitiated CoverageBuy$53.00High
10/23/2018UBS GroupLower TargetNeutral ➝ Neutral$59.00 ➝ $54.00High
10/8/2018UBS GroupLower TargetNeutral ➝ Neutral$62.00 ➝ $59.00Medium
7/24/2018Bank of AmericaBoost TargetBuy ➝ Buy$65.00 ➝ $68.00Low
7/16/2018Bank of AmericaBoost TargetBuy ➝ Buy$59.00 ➝ $65.00Low
6/21/2018Morgan StanleyDowngradeOverweight ➝ Equal Weight$63.00High
6/4/2018Buckingham ResearchBoost TargetBuy ➝ Buy$60.00 ➝ $69.00Low
4/24/2018Morgan StanleyBoost TargetOverweight ➝ Overweight$60.00 ➝ $63.00High
4/24/2018JMP SecuritiesBoost TargetMarket Outperform ➝ Market Outperform$55.00 ➝ $57.00High
(Data available from 3/26/2018 forward)

News Sentiment Rating

1.00 (Buy)

Our news sentiment rating is based on the average sentiment of articles about this company published in the media in the last 30 days of headlines and can range from 2 (very positive sentiment) to -2 (very negative sentiment).

News Sentiment Over Time

Move your mouse over past months for details

Skip to Current Sentiment Summary
  • 1 very positive mentions
  • 5 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
8/28/2022
  • 1 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 1 very negative mentions
Mentions as of
9/27/2022
  • 2 very positive mentions
  • 11 positive mentions
  • 2 negative mentions
  • 0 very negative mentions
Mentions as of
10/27/2022
  • 2 very positive mentions
  • 9 positive mentions
  • 2 negative mentions
  • 1 very negative mentions
Mentions as of
11/26/2022
  • 2 very positive mentions
  • 3 positive mentions
  • 0 negative mentions
  • 2 very negative mentions
Mentions as of
12/26/2022
  • 3 very positive mentions
  • 9 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
1/25/2023
  • 9 very positive mentions
  • 6 positive mentions
  • 1 negative mentions
  • 0 very negative mentions
Mentions as of
2/24/2023
  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions
Mentions as of
3/26/2023

Current Sentiment

  • 11 very positive mentions
  • 7 positive mentions
  • 0 negative mentions
  • 0 very negative mentions

Recent Stories by Sentiment

Very Negative

  • No very negative mentions tracked during this time.

Negative

  • No negative mentions tracked during this time.

Positive

Very Positive

Moelis & Company logo
Moelis & Co. operates as a holding company. It engages in the provision of financial advisory, capital raising and asset management services to a client base including corporations, governments, sovereign wealth funds and financial sponsors. The firm focuses on clients including large public multinational corporations, middle market private companies, financial sponsors, entrepreneurs and governments. The company was founded by Kenneth David Moelis, Navid Mahmoodzadegan, Jeffrey Raich and Elizabeth Ann Crain in July 2007 and is headquartered in New York, NY.
Read More

Today's Range

Now: $37.75
Low: $36.00
High: $37.82

50 Day Range

MA: $43.61
Low: $37.75
High: $49.34

52 Week Range

Now: $37.75
Low: $33.12
High: $50.23

Volume

820,274 shs

Average Volume

590,023 shs

Market Capitalization

$2.59 billion

P/E Ratio

17.56

Dividend Yield

6.22%

Beta

1.46

Frequently Asked Questions

What sell-side analysts currently cover shares of Moelis & Company?

The following equities research analysts have issued reports on Moelis & Company in the last year: JPMorgan Chase & Co., Keefe, Bruyette & Woods, Morgan Stanley, Piper Sandler, StockNews.com, The Goldman Sachs Group, Inc., UBS Group AG, and Wolfe Research.
View the latest analyst ratings for MC.

What is the current price target for Moelis & Company?

7 Wall Street analysts have set twelve-month price targets for Moelis & Company in the last year. Their average twelve-month price target is $38.86, suggesting a possible upside of 2.9%. Piper Sandler has the highest price target set, predicting MC will reach $45.00 in the next twelve months. UBS Group AG has the lowest price target set, forecasting a price of $30.00 for Moelis & Company in the next year.
View the latest price targets for MC.

What is the current consensus analyst rating for Moelis & Company?

Moelis & Company currently has 5 sell ratings and 2 hold ratings from Wall Street analysts. The stock has a consensus analyst rating of "Sell." A "sell" rating indicates that analysts believe MC will underperform the market and that investors should sell shares of Moelis & Company.
View the latest ratings for MC.

What other companies compete with Moelis & Company?

Other companies that are similar to Moelis & Company include StepStone Group, Artisan Partners Asset Management, Cohen & Steers, AssetMark Financial and Victory Capital. Learn More about companies similar to Moelis & Company.

How do I contact Moelis & Company's investor relations team?

Moelis & Company's physical mailing address is 399 PARK AVENUE 5TH FLOOR, NEW YORK NY, 10022. The asset manager's listed phone number is (212) 883-3800 and its investor relations email address is [email protected] The official website for Moelis & Company is www.moelis.com. Learn More about contacing Moelis & Company investor relations.